Palkon Capital is a U.S.-focused venture capital firm investing in private and public life sciences companies, with a concentrated, science-driven strategy focused on development-stage biopharma and unmet medical needs. The firm has acted as a lead investor and is relevant for biotechnology, pharmaceutical and oncology companies raising early- or later-stage venture capital.